Inovio Pharmaceuticals Inc (INO)
10.02
-0.14
(-1.38%)
USD |
NASDAQ |
Jun 03, 12:35
Inovio Pharmaceuticals Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0059M |
| March 31, 2023 | 0.0733M |
| December 31, 2022 | 1.702M |
| September 30, 2022 | 2.443M |
| June 30, 2022 | 4.483M |
| March 31, 2022 | 4.004M |
| December 31, 2021 | 5.467M |
| September 30, 2021 | 4.771M |
| June 30, 2021 | 13.13M |
| March 31, 2021 | 9.912M |
| December 31, 2020 | 18.56M |
| September 30, 2020 | 7.693M |
| June 30, 2020 | 3.513M |
| March 31, 2020 | 0.6416M |
| December 31, 2019 | 0.7001M |
| September 30, 2019 | 0.7763M |
| June 30, 2019 | 0.1302M |
| March 31, 2019 | 2.783M |
| December 31, 2018 | 3.316M |
| September 30, 2018 | 2.832M |
| June 30, 2018 | 1.713M |
| March 31, 2018 | 5.148M |
| December 31, 2017 | 6.003M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.237M |
| June 30, 2017 | 7.522M |
| March 31, 2017 | 9.865M |
| December 31, 2016 | 15.82M |
| September 30, 2016 | 17.46M |
| June 30, 2016 | 10.37M |
| March 31, 2016 | 11.15M |
| December 31, 2015 | 7.300M |
| September 30, 2015 | 10.97M |
| June 30, 2015 | 5.609M |
| March 31, 2015 | 3.300M |
| December 31, 2014 | 2.804M |
| September 30, 2014 | 1.622M |
| June 30, 2014 | 2.877M |
| March 31, 2014 | 2.700M |
| December 31, 2013 | 3.302M |
| September 30, 2013 | 10.57M |
| June 30, 2013 | 0.5403M |
| March 31, 2013 | 1.029M |
| December 31, 2012 | 0.8304M |
| September 30, 2012 | 0.4814M |
| June 30, 2012 | 0.4321M |
| March 31, 2012 | 0.8767M |
| December 31, 2011 | 0.4679M |
| September 30, 2011 | 0.4552M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2023
18.56M
Maximum
Dec 2020
4.105M
Average
2.443M
Median
Sep 2022
Accounts Receivable (Quarterly) Benchmarks
| Stereotaxis Inc | 3.953M |
| Novavax Inc | 21.38M |
| Sangamo Therapeutics Inc | 0.691M |
| Vaxart Inc | 0.556M |
| Capricor Therapeutics Inc | 0.369M |